Sergey Young, Longevity Vision Fund
Neil Littman, Bioverge
Longevity Investing
View keynote summary >

Kristen Fortney, Bioage
Building a pipeline of clinical-stage therapies to target aging
View keynote summary >

David Furman, Buck Institute
Systems Immunology of Aging to ​Enable Precision Preventative Medicine
View keynote summary >

Reason, Fight Aging
Atherosclerosis: The As Yet Undefeated Monster
View keynote summary >

Emil Kendziorra
Aschwin De Wolf
Biostasis & Cryonics Q&A
View keynote summary >

Alexander Fedintsev, lifespan.io
Biohacking – A necessary component of a strategy for radical life extension
View keynote summary >

Daniel Belsky, Columbia University
Terrie Moffitt, Duke University.
The DunedinPoAm DNA Methylation Algorithm
View keynote summary >

Michael Snyder, Stanford University
Monitoring Personal Health and Ageotypes Using Big Data
View keynote summary >

Michael Levin, Tufts Center for Regenerative and Developmental Biology
Bioelectric Networks: Taming the Collective Intelligence of Cells for Regenerative Medicine
View keynote summary >

Daniel Ives, Shift Bioscience
Drug Target Discovery for Cellular Rejuvenation by ‘Driver’ Clocks
View keynote summary >

Nir Barzilai, Albert Einstein School of Medicine
TAME Q&A: Lessons for Progress on Aging
View keynote summary >

Keith Murphy, Organovo, Viscient Biosciences
David Gobel, Methuselah Foundationt
Patient Trials in a Dish” Paths Forward
View keynote summary >

Morgan Levine, Yale
Jamie Justice, Wake Forest
Biomarker Standardization
View keynote summary >

Steve Horvath, UCLA
EpigeneticClocks: What’s New & What’s Missing?
View keynote summary >

Vadim Gladyshev, Harvard
Gordan Lauc, GlycanAge
Biomarker & Aging Clock Development
View keynote summary >

Alex Zhavoronkov, Deep Longevity & Insilico Medicine
Longevity as a Service: AI & Aging Clocks
View keynote summary >

Dylan Livingston, ALARMA
ALARMA (America’s Longevity, Aging and Regenerative Medicine Association)
View keynote summary >

Greg Fahy, Intervene Immune
Thymus Rejuvenation Progress Update
View keynote summary >

Christopher Leptak, CDER Biomarker Qualification Program, FDA
Biomarkers and Drug Development: Regulatory Perspective
View keynote summary >

James Peyer, Cambrian Biopharma
How to Fund and Build Geroprotectors
View keynote summary>

Ronald Kohanski, National Institute on Aging
Institutional perspective: What work could dramatically advance progress on aging from an NIA perspective?
View keynote summary >

James Kirkland, Mayo Clinic
Clinical Trials & Senolytics Q&A
View keynote summary >

Jean Hebert, Albert Einstein School of Medicine
Brain Cell Replacement as the Cornerstone to Beating Aging
View keynote summary >

Irina Conboy, UC Berkeley
Tissue Rejuvenation via Plasma Dilution
View keynote summary >